Skip to main content
SpringerLink
Log in

Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolaevulinic acid

  • Original Articles
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Photodynamic therapy (PDT) with topical application of 5-aminolaevulinic acid (ALA, 20% w/w) was used to treat superficial basal cell carcinoma (BCC, 16 patients), Morbus Bowen (one patient), basal cell naevus syndrome (BCNS, three patients), actinic keratosis (AK, two patients), chronic inflammation (CI, one patient), and metastasized BCC (one patient). The interval between ALA application and illumination was 3–6 h. The incident light dose was 50–100 J cm−2, mostly 75 J cm−2, at 633 nm wavelength. This was based on the fluorescence excitation spectrum, measured on the skin of human volunteers. In a few cases, 514.5 nm light was used. A complete response (CR) rate of 79% (median follow-up 13 months) was obtained with 42 BCC lesions. The treatment of five areas with AK, two areas with CI and one area with M. Bowen yielded three CR for AK and five partial remissions (PR). Photodynamic therapy of metastasized BCC, after either topical or oral ALA, was not successful. Treatment of BCNS was satisfactory with 100% CR in one patient (22 lesions), PR in a second patient (20 lesions), and good palliation in a third patient (>250 lesions). The treatment was well tolerated, although the illumination had to be interrupted occasionally due to pain. Healing usually occurred in 2 weeks. Cosmetic results were good to excellent. 5-Aminolaevulinic acid application over 16–19 h and repeated treatments made it possible to obtain CR of non-superficial lesions. The selective tumour fluorescence was then lost, however, due to fluorescence of normal skin, but the cosmetic outcome did not deteriorate. 5-Aminolaevulinic acid PDT may be a good alternative outpatient treatment, especially in elderly patients and for large treatment areas. The excellent cosmetic outcome warrants further study in younger patients. More work is necessary to establish optimal ALA-treatment schemes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Preston DS, Stern RS. Nonmelanoma cancers of the skin.N Engl J Med 1992,327:1649–62

    PubMed  Google Scholar 

  2. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in the photoactivation of a murine tumour.Cancer Res 1976,36:2326–9

    PubMed  Google Scholar 

  3. Wilson BD, Mang TS, Stoll H et al. Photodynamic therapy for the treatment of basal cell carcinomaArch Dermatol 1992,128:1597–1601

    PubMed  Google Scholar 

  4. Buscaglia DA, Shanler SD, Mang TS et al. Photodynamic therapy with Photofrin II successfully treats basal cell carcinomas in patients with basal cell nevus syndrome.J Invest Dermatol 1994,102:615

    Google Scholar 

  5. Robinson PJ, Carruth JAS, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease.Br J Dermatol 1988,119:59–61

    PubMed  Google Scholar 

  6. Jones CM, Mang T, Cooper M et al. Photodynamic therapy in the treatment of Bowen's disease.J Am Acad Dermatol 1992,27:979–82

    PubMed  Google Scholar 

  7. Razum N, Balchum OJ, Profio AE et al. Skin photosensivity: duration and intensity following intravenous hematoporphyrin derivatives, HpD and DHE.Photochem Photobiol 1987,46:925–8

    PubMed  Google Scholar 

  8. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving photofrin.Lasers Surg Med 1990,10:485–8

    PubMed  Google Scholar 

  9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.J Photochem Photobiol B: Biology 1990,6:143–8

    Google Scholar 

  10. Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence.Am J Pathol 1990,136:891–7

    PubMed  Google Scholar 

  11. Pottier RH, Chow YFA, LaPlante JP et al. Noninvasive technique for obtaining fluorescence excitation and emission spectra in vivo.Photochem Photobiol 1986,44:679–87

    PubMed  Google Scholar 

  12. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.J Photochem Photobiol B: Biology 1992,14:275–92

    Google Scholar 

  13. Star WM, Versteeg AAC, Van Putten WLJ, Marijnissen JPA. Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears.Photochem Photobiol 1990,52:547–54

    PubMed  Google Scholar 

  14. Star WM. In vivo action spectra, absorption and fluorescence excitation spectra of photosensitizers for photodynamic therapy.J Photochem Photobiol B: Biology 1995,28:101–2

    Google Scholar 

  15. Gijsbers GHM, Breederveld D, Van Gemert MJC et al. In vivo fluorescence excitation and emission spectra of hematoporphyrin derivative.Lasers Life Sci 1987,1:29–48

    Google Scholar 

  16. Grant WE, Hopper C, MacRobert AJ et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid.Lancet 1993,342:147–8

    PubMed  Google Scholar 

  17. Loh CS, MacRobert AJ, Bedwell J et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.Br J Cancer 1993,68:41–51

    PubMed  Google Scholar 

  18. Szeimies RM, Abels C, Fritsch C et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo.J Invest Dermatol 1995,105:672–7

    PubMed  Google Scholar 

  19. Elton RF. Cryosurgical advances and difficult cancers of the skin. In: Zacarion SA (ed)Cryosurgical Advances in Dermatology and Tumors of the Head and Neck. Springfield, Ill.: CC Thomas, 1977:150–70

    Google Scholar 

  20. Torre D. Cryosurgery in cancer. In: Andrade R (ed)Cancer of the Skin. Philadelphia: WB Saunders, 1976:1583–4

    Google Scholar 

  21. Menn H, Robins P, Kopf AW et al. The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epitheliomas.Arch Dermatol 1971,103:628–31

    PubMed  Google Scholar 

  22. Sakura CY, Calamel PM. Comparison of treatment modalities for recurrent basal cell carcinoma.Plast Reconstr Surg 1979,63:492–6

    PubMed  Google Scholar 

  23. Hauben DJ. The biologic behaviour of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma.Plast Reconstr Surg 1982,69:103–16

    PubMed  Google Scholar 

  24. Scholten AN, Griep C, Davelaar J et al. Electron beam therapy is effective in the treatment of skin carcinoma; a comparison with superficial X-ray therapy.Ned Tijdschr Geneeskd 1996,140(8):428–31

    PubMed  Google Scholar 

  25. Cairnduff F, Stringer MR, Hudson EJ et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.Br J Cancer 1994,69:605–8

    PubMed  Google Scholar 

  26. Calzavara Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.J Photochem Photobiol B: Biology 1995,29:53–7

    Google Scholar 

  27. Orenstein A, Kostenich G, Tsur H et al. Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA. In: Brault D, Jori G, Moan J, Ehrenberg B (eds)Photodynamic Therapy of Cancer II. Proceedings of SPIE 1995,2325:100–5

  28. Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation.Br J Dermatol 1994,130:743–51

    PubMed  Google Scholar 

  29. Warloe T, Peng Q, Heyerdahl H et al. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In: Cortese DA (ed)Fifth International Photodynamic Association Biennial Meeting. Proceedings of SPIE 1995,2371: 226–35

  30. Szeimies RM, Sassy T, Landthaler M. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma.Photochem Photobiol 1994,59:73–6

    PubMed  Google Scholar 

  31. Peng Q, Warloe T, Moan J et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.Photochem Photobiol 1995,62:906–13

    PubMed  Google Scholar 

  32. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using deltaaminolaevulinic acid and desferrioxamine.Br J Dermatol 1995,133:282–8

    PubMed  Google Scholar 

  33. Lui H, Salasche S, Kollias N et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study.Arch Dermatol 1995,131:737–8

    PubMed  Google Scholar 

  34. Messman H, Mlkvy P, Buonaccorsi G et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.Br J Cancer 1995,72:589–94

    PubMed  Google Scholar 

  35. Hua Z, Gibson SL, Foster TH et al. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.Cancer Res 1995,55:1723–31

    PubMed  Google Scholar 

  36. Van der Veen N, Van Leengoed HLLM, Star WM.In vivo fluorescence kinetics and photodynamic therapy using ALA-induced porphyrin: increased damage after multiple irradiations.Br J Cancer 1994,70:867–72

    PubMed  Google Scholar 

  37. Shanler SD, Buscaglia DA, Van Leengoed E et al. PDT with topical δ-aminolevulinic acid for treatment of patch and plaque stage cutaneous T-cell lymphoma.J Invest Dermatol 1994,102:615

    Google Scholar 

  38. Wolf P, Fink-Puches R, Cerroni L et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.J Am Acad Dermatol 1994,31:678–80

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, Dr. Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands

    P. J. N. Meijnders, A. D. Treurniet-Donker, M. J. M. Van Mierlo & P. C. Levendag

  2. Department of Clinical Physics (Photodynamic Therapy Laboratory), Dr. Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands

    W. M. Star & R. S. De Bruijn

  3. Department of Plastic Surgery, Dr. Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands

    S. J. M. Wijthoff

  4. Department of Dermatology, Dijkzigt Hospital, University Hospital, Rotterdam, The Netherlands

    B. Naafs

  5. Department of Pathology, Dr. Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands

    H. Beerman

Authors
  1. P. J. N. Meijnders
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. M. Star
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. S. De Bruijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. D. Treurniet-Donker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. J. M. Van Mierlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. J. M. Wijthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Naafs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Beerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. C. Levendag
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meijnders, P.J.N., Star, W.M., De Bruijn, R.S. et al. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolaevulinic acid. Laser Med Sci 11, 123–131 (1996). https://doi.org/10.1007/BF02133209

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02133209

Key words

Search

Navigation